Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;30(3):339-352.
doi: 10.1111/pcmr.12579. Epub 2017 Apr 19.

Hypoxia-induced HIF1α targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis

Collaborators, Affiliations

Hypoxia-induced HIF1α targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis

Stacie K Loftus et al. Pigment Cell Melanoma Res. 2017 May.

Abstract

Hypoxia and HIF1α signaling direct tissue-specific gene responses regulating tumor progression, invasion, and metastasis. By integrating HIF1α knockdown and hypoxia-induced gene expression changes, this study identifies a melanocyte-specific, HIF1α-dependent/hypoxia-responsive gene expression signature. Integration of these gene expression changes with HIF1α ChIP-Seq analysis identifies 81 HIF1α direct target genes in melanocytes. The expression levels for 10 of the HIF1α direct targets - GAPDH, PKM, PPAT, DARS, DTWD1, SEH1L, ZNF292, RLF, AGTRAP, and GPC6 - are significantly correlated with reduced time of disease-free status in melanoma by logistic regression (P-value = 0.0013) and ROC curve analysis (AUC = 0.826, P-value < 0.0001). This HIF1α-regulated profile defines a melanocyte-specific response under hypoxia, and demonstrates the role of HIF1α as an invasive cell state gatekeeper in regulating cellular metabolism, chromatin and transcriptional regulation, vascularization, and invasion.

Keywords: HIF1α; hypoxia; melanocyte; melanoma; metastasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Hypoxia and HIF1α knockdown induce melanocyte target gene expression changes
(A) The migratory ability of melan-Ink4a-Arf−/− cells is significantly increased by 24 hr hypoxia exposure (***, P<0.0001). Representative images of migration wells for cells grown for 24 hr under normoxia (22% O2) and hypoxia (1% O2) are shown below the graph. (B) HIF1α protein is stabilized by 24 hr hypoxia, and HIF1α protein expression under hypoxia is eliminated by siHif1α treatment. Molecular weights: HIF1α=95 kDa, Tubulin = 50 kDa. (C) Hif1α mRNA levels are unchanged under hypoxia, consistent with HIF1α protein stabilization regulating signaling activity. Hif1α mRNA levels are significantly reduced by multiple siRNAs (**, P=0.0015). The mRNA expression levels of the known HIF1α target genes Kdm3a and Gapdh are significantly increased by 24 hr hypoxia (*, P<0.05), and are significantly downregulated with siHif1α KD under hypoxia, returning to near-normoxic levels (*, P<0.05). (D) 709 hypoxia-responsive genes were differentially expressed 1.5 fold under normoxia vs. hypoxia growth conditions. Ingenuity Pathway Analysis (IPA) predicted distinct upstream regulatory factors for upregulated and downregulated gene cohorts, listed at right. See Table S1 for the complete list of 709 hypoxia-responsive genes. (E) 712 HIF1α-dependent genes were differentially expressed 1.5-fold in both siHif1α KD RNAs as compared to non-silencing control. IPA predicted distinct upstream regulatory factors for upregulated and downregulated gene cohorts, listed at right. See Table S4 for the complete list of 712 HIF1α-dependent genes. Details of IPA analysis for predicted transcriptional regulators and downstream targets for the hypoxia-responsive genes and the HIF1α-dependent genes are in Tables S2 and S5, respectively. Norm = normoxia; Hpx = hypoxia; Ctr = control si; si1 and si6 = independent HIF1α-directed siRNA constructs.
Figure 2
Figure 2. HIF1α-ChIP in melanocyte cells under hypoxia
A) Validation of significant HIF1α binding enrichment at proximal promoters of the known HIF1α target genes KDM6B and KDM3A in melanocytes as compared to IgG negative controls and a negative control genomic region on Chr 6 (***, P<0.0001). (B) Representative diagram showing that the HIF1α-ChIP bioreplicated peaks led to the identification of 591 genes with a HIF1α-ChIP peak located within +/− 5kb of their annotated TSSs. (C) Location of the 1773 replicated HIF1α-ChIP peaks with respect to RefSeq annotated gene structures. (D) Pathway enrichment analysis validates that the set of 591 genes with HIF1α-ChIP peaks located within +/− 5kb of TSSs are enriched for known HIF1α target genes. See Tables S8 and S9 for the complete lists of 1773 replicated HIF1α-ChIP peaks and 591 genes, respectively.
Figure 3
Figure 3. Identification of 81 HIF1α direct target genes in melanocytes
A) Venn diagram illustrating the intersections of genes with HIF1α-ChIP peaks (light orange), HIF1α-dependent genes (purple), and hypoxia-responsive genes (red). (B) Quantitative gene expression for siHIF1α KD in 501mel cells under 24 hr hypoxia for four of the 81 HIF1α direct target genes verifies gene expression changes under siHIF1α KD (*, P<0.05; **, P<0.01; ***, P<0.001). HIF1α is included as a positive control. (C) Centrimo motif analysis for the 89 peaks within +/− 5kb of TSSs for the 81 HIF1α direct target genes finds that the top three enriched motifs (labeled 1, 2, and 3 in red, blue, and black, respectively) are consistent with the RCGTG HIF1α:ARNT consensus. (D) Consensus motif profiles near HIF1α-ChIP peak summits for the 89 peaks. Red, blue, and black line colors match the top 3 motifs shown in C. See Table S10 for the complete list of 81 HIF1α direct target genes.
Figure 4
Figure 4. HIF1α direct targets correlate with DFS in primary melanoma tumors
A–B) DFS plots (% Disease Free Status versus time in months) for primary melanoma tumor expression of the 10 HIF1α direct target genes with significant P-value correlating gene expression with increased severity of DFS. A) AGTRAP, PKM, and GAPDH show reduced expression (25% lowest expression tumors, blue) correlating with poor prognosis/shorter DFS time. B) DTWD1, SEH1L, ZNF292, DARS, GPC6, PPAT, and RLF show increased expression (25% highest expression tumors, red) correlating with poor prognosis/shorter DFS time. C) Table of the 10 HIF1α direct target genes with associated P-values and FDR values for individual correlation with DFS. D) ROC curve analysis for the set of DFS-associated HIF1α direct target genes demonstrating the degree to which this set of 10 genes is predictive of DFS.
Figure 5
Figure 5. HIF1α direct target gene validation
A) Quantitative PCR verifies that HIF1α binding is significantly enriched at the proximal promoters of the novel HIF1α target loci AGTRAP, DTWD1, and SEH1L (***, P<0.0001). B) Western blot shows that HIF1α is induced by hypoxia in 501mel melanoma cells, and this expression is reduced with multiple siHIF1α RNAs. N = normoxia; H = hypoxia; C = control siRNA. Molecular weights: HIF1α=95 kDa, Tubulin = 50 kDa. C) The DFS-associated, HIF1α direct target genes show significantly altered expression upon HIF1α KD in 501mel cells (*, P<0.05; **, P<0.01; ***, P<0.001). No detectable expression was observed for GPC6 in 501mel cells (data not shown). HIF1α and KDM3A were included as controls.
Figure 6
Figure 6. Hierarchical cluster analysis of primary melanoma tumors correlates with DFS prognosis
Hierarchical clustering of 88 primary tumors (rows) relative to expression levels of the ten DFS-associated, HIF1α direct target genes (columns) is shown by the dendrograms and associated blue/gray/red blocks. Columns to the right of the cluster analysis show both a tally and a horizontal bar equal to the number of times each tumor was present in the highest or lowest 25% of tumors based upon rank gene expression of the 10 DFS-associated, HIF1α direct target genes, as was used in the Figure 4 DFS plots. The horizontal blue bars correspond to longer time of DFS/good prognosis, and the horizontal red bars correspond to shorter time of DFS/poor prognosis.

References

    1. Afgan E, Baker D, van den Beek M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44:W3–W10. - PMC - PubMed
    1. Bailey TL, Machanick P. Inferring direct DNA binding from ChIP-seq. Nucleic Acids Res. 2012;40:e128. - PMC - PubMed
    1. Barderas R, Mendes M, Torres S, Bartolomé RA, López-Lucendo M, Villar-Vázquez R, Peláez-García A, Fuente E, Bonilla F, Casal JI. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion. Mol Cell Proteomics. 2013;12:1602–1620. - PMC - PubMed
    1. Bauer J, Büttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, Scolyer RA, Bastian BC. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pig Cell Mel Res. 2011;24:345–351. - PMC - PubMed
    1. Bedogni B, Powell MB. Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin. Pig Cell Mel Res. 2009;22:166–174. - PMC - PubMed

Publication types

Substances